Skip to main content
SpringerLink
Log in

Uses of Radiopharmaceuticals in Nuclear Medicine

  • Chapter
Fundamentals of Nuclear Pharmacy

Abstract

In previous chapters, we described various characteristics and production of radionuclides, preparation of different radiopharmaceuticals using various radionuclides, and their quality control. In the present chapter we shall discuss clinical applications of these radiopharmaceuticals in the diagnosis of various diseases in humans. The discussion is primarily divided into sections on different human organs. In each section the anatomic structure and physiologic function of the organ are briefly described and appropriate nuclear medicine tests are discussed along with their clinical usefulness, particularly with respect to the radiopharmaceuticals used, their pharmacologic aspect, the mechanism of their localization, and diagnosis of various diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Suggested Reading

  • Anghileri LJ, ed. General Processes of Radiotracer Localization. Boca Raton, Fla: CRC Press; 1982.

    Google Scholar 

  • Anthony CP, Thibodeau GA. Textbook of Anatomy and Physiology. St Louis: Mosby; 1979.

    Google Scholar 

  • Arnold RW, Subramanian G, McAfee JG, et al. Comparison of 99mTc complexes for renal imaging. J Nucl Med. 1975; 16 : 357.

    PubMed  CAS  Google Scholar 

  • Atkins HL, Budinger TF, Lebowitz E, et al. Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties. J Nucl Med. 1977; 18 : 133.

    PubMed  CAS  Google Scholar 

  • Bernier DR, Lang JK, Wells LD. Nuclear Medicine Technology and Techniques. St Louis: Mosby; 1981.

    Google Scholar 

  • Bland WH, ed. Nuclear Medicine. 2nd ed. New York: McGraw-Hill; 1972.

    Google Scholar 

  • Colombetti LG, ed. Principles of Radiopharmacology. Boca Raton, Fla: CRC Press; 1979; I-III.

    Google Scholar 

  • Dilsizian V, Rocco TP, Freedman NMT, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium and stress-redistribution imaging. N Engl J Med. 1990; 323 : 141.

    Article  PubMed  CAS  Google Scholar 

  • Early PJ, Sodee DB, eds. Principles and Practice of Nuclear Medicine. St. Louis: Mosby; 1985.

    Google Scholar 

  • Freeman LM, ed. Freeman and Johnson’s Clinical Radionuclide Imaging. 3rd ed. New York: Grune & Stratton; 1984.

    Google Scholar 

  • Gallagher BM, Anasri A, Atkins H, et al. Radiopharmaceuticals XXVII. 18Flabeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med. 1977; 18 : 990.

    PubMed  CAS  Google Scholar 

  • Gould KL. Myocardial metabolism by positron emission tomography in hypertropic cardiomyopathy. J Am Coll Cardiol. 1989; 13 : 325.

    Article  PubMed  CAS  Google Scholar 

  • Greenfield LD, Uszler JM. Nuclear medicine in clinical practice. Deerfield Beach, Fla: Verlag Chemie International; 1982.

    Google Scholar 

  • Harbert J, Rocha AFG, eds. Textbook of Nuclear Medicine, Vol II: Clinical Applications. Philadelphia: Lea & Febiger; 1984.

    Google Scholar 

  • Hauser W, Atkins HL, Nelson KG, et al. Technetium-99m-DTPA: a new radiopharmaceutical for brain and kidney imaging. Radiology. 1970; 94 : 679.

    PubMed  CAS  Google Scholar 

  • Hladik WB, III, Ponto JA, Lentle BC, et al. Iatrogenic alterations in the biodistribution of radiotracers as a result of drug therapy: reported instances. In: Hladik WB, III, Saha GB, Study KT, eds. Essentials of Nuclear Medicine Science. Baltimore, Md: Williams and Wilkins; 1987; 189.

    Google Scholar 

  • Johnson LL, Seldin DW. Clinical experience with technetium-99m Teboroxime, a neutral, lipophilic myocardial perfusion imaging agent. Am J Cardiol. 1990; 66 : 63E.

    Article  Google Scholar 

  • Keyes JW, Jr. Manual of Nuclear Medicine Procedures. 3rd ed. Boca Raton, Fla: CRC Press; 1978.

    Google Scholar 

  • Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin specific antibody. Circulation. 1986; 74 : 501.

    Article  PubMed  CAS  Google Scholar 

  • Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial T1–201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988; 12(6) :1456.

    Article  PubMed  CAS  Google Scholar 

  • Kuhl DE, Barrio JR, Huang SC, et al. Quantifying local cerebral blood flow by N-isopropyl-p-123I-iodoamphetamine (IMP) tomography. J Nucl Med. 1982; 236:196.

    Google Scholar 

  • Leveille J, Demonceau G, De Roo M, et al. Characterization of technetium-99mL,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans. J Nucl Med. 1989; 30 : 1902.

    PubMed  CAS  Google Scholar 

  • Maisey MN, Britton KE, Gilday D, eds. Clinical Nuclear Medicine. London: Chapman and Hall; 1983.

    Google Scholar 

  • McAfee JG, Grossman ZD, Gagne G, et al. Comparison of renal extraction efficiencies for radioactive agents in the normal dog. J Nucl Med. 1981; 22 : 333.

    PubMed  CAS  Google Scholar 

  • Mettler FA, Jr, Guiberteau MJ. Essentials of Nuclear Medicine Imaging. 3rd ed. New York: Grune & Stratton; 1991.

    Google Scholar 

  • Narra RK, Nunn AD, Kuczynski, et al. A neutral technetium-99m complex for myocardial imaging. J Nucl Med. 1989; 30 : 1830.

    PubMed  CAS  Google Scholar 

  • Phelps ME, Hoffman EJ, Selin C, et al. Investigation of F-18-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med. 1978; 19 : 1311.

    PubMed  CAS  Google Scholar 

  • Saha GB, Go RT, Maclntyre WJ, et al. Use of 82Sr/82Rb generator in clinical PET studies. Nucl Med Biol. 1990; 17 : 763.

    CAS  Google Scholar 

  • Sapirstein LA, Vigt DG, Mandel MJ, et al. Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol. 1955; 181 : 330.

    PubMed  CAS  Google Scholar 

  • Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981; 63 : 1259.

    Article  PubMed  CAS  Google Scholar 

  • Sharp PF, Smith FW, Gemmell HG, et al. Technetium-99m HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med. 1986; 27 : 171.

    PubMed  CAS  Google Scholar 

  • Soin JS, Brooks HL, eds. Nuclear Cardiology for Clinicians. New York: Futura; 1980.

    Google Scholar 

  • Subramanian G, McAfee JG, Blair RJ, et al. Technetium 99m methylene diphosphonate—a superior agent for skeletal imaging; comparison with other technetium complexes. J Nucl Med. 1975; 16 : 744.

    PubMed  CAS  Google Scholar 

  • Taylor A, Jr, Eshima D, Fritzberg AR, et al. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers. J Nucl Med. 1986; 27 : 795.

    PubMed  Google Scholar 

  • Taylor A, Jr, Eshima D, Christian PE, et al. Technetium-99m kit formulation: preliminary results in normal volunteers and patients with renal failure. J Nucl Med. 1988; 29 616.

    PubMed  Google Scholar 

  • Vallabhajoshula S, Zimmerman RE, Pickard M, et al. Technetium-99m ECD: a new brain imaging agent. In vivo kinetics and biodistribution studies in normal human studies. J Nucl Med. 1989; 30 : 599.

    Google Scholar 

  • Wackers FJT, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989; 30: 301.

    PubMed  CAS  Google Scholar 

  • Wistow BW, Subramaniam G, Gagne GM, et al. Experimental and clinical trials of new 99mTc-labeled hepatobiliary agents. Radiology. 1978; 128 : 793.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, The Cleveland Clinic Foundation, 44195, Cleveland, OH, USA

    Gopal B. Saha Ph.D. (Director of Nuclear Chemistry and Pharmacy)

Authors
  1. Gopal B. Saha Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Saha, G.B. (1992). Uses of Radiopharmaceuticals in Nuclear Medicine. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4027-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4027-1_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-4029-5

  • Online ISBN: 978-1-4757-4027-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation